VTXPF Stock Chart & Stats
$7.74
--
Market closed
$7.74
--
Day’s Range― - ―
52-Week Range$7.15 - $11.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)180.00
Market Cap
$844.38M
Enterprise Value$588.75M
Total Cash (Recent Filing)$31.70M
Total Debt (Recent Filing)$77.10M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Dec 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.87%
Share Statistics
EPS (TTM)-0.23
Shares Outstanding87,124,916
10 Day Avg. Volume0
30 Day Avg. Volume180
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)1.44
Price to Sales (P/S)2.11
P/FCF Ratio12.71
Enterprise Value/Market Cap0.70
Enterprise Value/Revenue2.00
Enterprise Value/Gross Profit4.66
Enterprise Value/Ebitda8.93
Forecast
1Y Price Target
$8.13Price Target Upside4.98% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)$4.02M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVictrex's very low leverage and high equity backing provide durable financial flexibility. This balance sheet strength supports investment in R&D, capital expenditure and qualification programs, lets the firm weather cyclical end-market volatility, and sustains dividend policy over multiple quarters.
High Gross Margins From Specialty PolymersA ~45% gross margin reflects pricing power from specialized PAEK/PEEK products sold into demanding markets. Durable margin advantages arise from technical barriers, formulation know-how and value-added grades, enabling long-term reinvestment, margin resilience and stronger cash conversion when volumes recover.
Long Qualification Cycles / Sticky DemandExtended customer qualification and approval processes in automotive, aerospace and medical create high switching costs. Once certified, Victrex secures recurring material demand and multi-year revenue visibility, supporting stable sales from qualified platforms and justifying upfront technical support investments.
Bears Say
Flat To Declining RevenueRevenue contraction, even modest, signals either end-market softness or share pressure in key sectors. Over 2-6 months, continued flat/negative top-line growth can limit scale benefits, pressure operating leverage and constrain resources available for market development and new qualification programs.
Falling Free Cash FlowA near-24% drop in free cash flow reduces internal funding for capex, R&D and dividends. Persistently weaker FCF undermines financial flexibility, risks higher external financing for growth or acquisitions, and may force tighter capital allocation during periods when qualification-led revenue ramps are required.
Weaker Profitability & EPS VolatilityDeclining ROE and sharply negative EPS growth indicate pressure on returns to shareholders and earnings quality. If profitability weakness persists it will limit ability to expand margins, sustain dividends and invest in high-cost medical or aerospace qualifications that drive long-term growth.
Victrex News
VTXPF FAQ
What was Victrex PLC’s price range in the past 12 months?
Victrex PLC lowest stock price was $7.15 and its highest was $11.50 in the past 12 months.
What is Victrex PLC’s market cap?
Victrex PLC’s market cap is $844.38M.
When is Victrex PLC’s upcoming earnings report date?
Victrex PLC’s upcoming earnings report date is Dec 08, 2026 which is in 136 days.
How were Victrex PLC’s earnings last quarter?
Victrex PLC released its earnings results on May 11, 2026. The company reported $0.233 earnings per share for the quarter, beating the consensus estimate of N/A by $0.233.
Is Victrex PLC overvalued?
According to Wall Street analysts Victrex PLC’s price is currently Undervalued.
Does Victrex PLC pay dividends?
Victrex PLC pays a Semiannually dividend of $0.181 which represents an annual dividend yield of 8.87%. See more information on Victrex PLC dividends here
What is Victrex PLC’s EPS estimate?
Victrex PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Victrex PLC have?
Victrex PLC has 87,124,916 shares outstanding.
What happened to Victrex PLC’s price movement after its last earnings report?
Victrex PLC reported an EPS of $0.233 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.367%.
Which hedge fund is a major shareholder of Victrex PLC?
Currently, no hedge funds are holding shares in VTXPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Victrex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.13 (4.98% Upside)
$8.13 (4.98% Upside)
Blogger Sentiment
Bullish
VTXPF Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.47%
12-Months-Change
Fundamentals
Return on Equity
8.87%
Trailing 12-Months
Asset Growth
-13.25%
Trailing 12-Months
Company Description
Victrex PLC
Operating globally through its subsidiaries, Victrex plc is a specialized producer and distributor of polymer materials. The company organizes its business into two core divisions: Industrial and Medical. It concentrates on creating PEEK and PAEK polymer-based solutions, delivering both partially processed and fully manufactured components. Furthermore, Victrex offers tailored solutions for medical device producers, markets thermoplastic polymer components, and conducts trading operations. Its diverse clientele spans the automotive, aerospace, energy, industrial, manufacturing, engineering, electronics, and healthcare industries. Established in 1993, Victrex plc maintains its corporate headquarters in Thornton-Cleveleys, United Kingdom.
VTXPF Stock 12 Month Forecast
Average Price Target
$8.13
▲(4.98% Upside)
Ownership Overview
0.17% Insiders
7.17% Mutual Funds
0.24% Other Institutional Investors
80.84% Public Companies and
Individual Investors